Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CLLS compared with NRXP: revenue, margins and what each company keeps, and the suppliers and customers both name
CLLS
Cellectis S.A.
Change
Mkt cap
Revenue
Revenue
NRXP
NRX Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CLLS
Cellectis S.A.
vs
NRXP
NRX Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
CLLS: latest quarter not drawable. NRXP: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CLLS
4
TMO
Life Technologies
supplier
ALLO
Allogene Therapeutics
customer
AZN
AstraZeneca AB (AZ Ireland)
customer
—
Servier
unlisted
customer
Shared
0
No shared counterparties.
Only NRXP
3
—
Nephron Pharmaceuticals
unlisted
supplier
—
Emobot
unlisted
supplier
—
Relief Therapeutics
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CLLS, solid
NRXP, dashed
CLLS
Cellectis S.A.
Change
1.11
· pre 1.11
· delayed
Mkt cap
$108.4M
Revenue
—
NRXP
NRX Pharmaceuticals, Inc.
Change
2.28
· pre 2.29
Pre-market
Sep 2 '83
Mkt cap
$98.3M
Revenue
$6,000
Q2 FY26
vs
Compare
Pre-market
Sep 2 '83
CLLS
Cellectis S.A.
vs
NRXP
NRX Pharmaceuticals, Inc.
1.11
pre 1.11
delayed
Price
2.28
pre 2.29
$108.4M
Mkt cap
$98.3M
—
Revenue
$6,000
Q2 FY26
Change
Change
CLLS
1.11
vs
NRXP
2.28
Pre-market
Sep 2 '83